Currency In USD
| Previous Close | 22.89 |
| Open | 22.5 |
| Day High | 23.4 |
| Day Low | 22.5 |
| 52-Week High | 35.95 |
| 52-Week Low | 16.05 |
| Volume | 53,072 |
| Average Volume | 51,619 |
| Market Cap | 211.87M |
| PE | -385.33 |
| EPS | -0.06 |
| Moving Average 50 Days | 21 |
| Moving Average 200 Days | 23.33 |
| Change | 0.23 |
Sanara MedTech Inc. Announces Publication of Peer-Reviewed Study Evaluating the Economic and Clinical Value of CellerateRX® Surgical Powder in the Management of Spine Surgery Wounds
GlobeNewswire Inc.
Mar 11, 2026 11:30 AM GMT
Study demonstrates cost savings and improved health outcomes associated with the use of CellerateRX® as an adjunct to the standard of care for high-risk spinal surgery patients, compared to the standard of care alone FORT WORTH, TX, March 11, 2026 (
Sanara MedTech Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026
GlobeNewswire Inc.
Mar 03, 2026 12:30 PM GMT
FORT WORTH, TX, March 03, 2026 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clin
Sanara MedTech Inc. to Participate in the TD Cowen 46th Annual Health Care Conference on March 3rd
GlobeNewswire Inc.
Feb 17, 2026 12:30 PM GMT
FORT WORTH, TX, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clini